COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 125 filers reported holding COHERUS BIOSCIENCES INC in Q4 2016. The put-call ratio across all filers is 4.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,705,411 | +19.6% | 723,372 | +36.5% | 0.00% | 0.0% |
Q2 2023 | $2,262,772 | -34.5% | 529,923 | +4.9% | 0.00% | 0.0% |
Q1 2023 | $3,455,855 | -13.9% | 505,242 | -0.3% | 0.00% | 0.0% |
Q4 2022 | $4,013,769 | -15.2% | 506,789 | +2.9% | 0.00% | -50.0% |
Q3 2022 | $4,732,000 | +37.3% | 492,343 | +3.4% | 0.00% | +100.0% |
Q2 2022 | $3,447,000 | -42.9% | 475,997 | +1.8% | 0.00% | -50.0% |
Q1 2022 | $6,036,000 | -20.4% | 467,505 | -1.6% | 0.00% | 0.0% |
Q4 2021 | $7,585,000 | +1.0% | 475,237 | +1.7% | 0.00% | 0.0% |
Q3 2021 | $7,511,000 | +14.2% | 467,358 | -1.7% | 0.00% | 0.0% |
Q2 2021 | $6,579,000 | -3.6% | 475,678 | +1.9% | 0.00% | -33.3% |
Q1 2021 | $6,823,000 | -22.6% | 466,943 | -7.9% | 0.00% | 0.0% |
Q4 2020 | $8,815,000 | -6.6% | 507,173 | -1.5% | 0.00% | -25.0% |
Q3 2020 | $9,441,000 | -14.5% | 514,772 | -16.8% | 0.00% | -20.0% |
Q2 2020 | $11,047,000 | +8.9% | 618,490 | -1.1% | 0.01% | -16.7% |
Q1 2020 | $10,148,000 | -15.2% | 625,603 | -5.9% | 0.01% | 0.0% |
Q4 2019 | $11,974,000 | +55.6% | 664,993 | +75.1% | 0.01% | +20.0% |
Q3 2019 | $7,697,000 | -0.5% | 379,885 | +8.6% | 0.01% | 0.0% |
Q2 2019 | $7,734,000 | +77.5% | 349,933 | +9.6% | 0.01% | +66.7% |
Q1 2019 | $4,356,000 | +58.9% | 319,349 | +5.5% | 0.00% | +50.0% |
Q4 2018 | $2,741,000 | -45.1% | 302,840 | +0.1% | 0.00% | -33.3% |
Q3 2018 | $4,994,000 | +39.2% | 302,611 | +18.1% | 0.00% | 0.0% |
Q2 2018 | $3,587,000 | +53.8% | 256,214 | +21.4% | 0.00% | +50.0% |
Q1 2018 | $2,333,000 | +39.7% | 211,070 | +11.3% | 0.00% | +100.0% |
Q4 2017 | $1,670,000 | -20.7% | 189,697 | +20.3% | 0.00% | -50.0% |
Q3 2017 | $2,106,000 | -9.1% | 157,681 | -2.3% | 0.00% | 0.0% |
Q2 2017 | $2,316,000 | -18.5% | 161,366 | +20.2% | 0.00% | -33.3% |
Q1 2017 | $2,841,000 | -15.5% | 134,302 | +12.4% | 0.00% | -25.0% |
Q4 2016 | $3,363,000 | +10.3% | 119,464 | +4.9% | 0.00% | 0.0% |
Q3 2016 | $3,049,000 | +69.7% | 113,833 | +7.0% | 0.00% | +100.0% |
Q2 2016 | $1,797,000 | +66.7% | 106,337 | +109.4% | 0.00% | +100.0% |
Q1 2016 | $1,078,000 | -6.3% | 50,771 | +1.3% | 0.00% | -50.0% |
Q4 2015 | $1,151,000 | +16.5% | 50,108 | +1.7% | 0.00% | +100.0% |
Q3 2015 | $988,000 | -27.2% | 49,263 | +4.8% | 0.00% | -50.0% |
Q2 2015 | $1,358,000 | +130.2% | 46,987 | +143.8% | 0.00% | +100.0% |
Q1 2015 | $590,000 | +159.9% | 19,276 | +39.0% | 0.00% | – |
Q4 2014 | $227,000 | – | 13,864 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |